JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on May 13, 2008; DOI: 10.1124/jpet.108.136432


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.108.136432v1
326/2/453    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hollenberg, M. D.
Right arrow Articles by Ramachandran, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hollenberg, M. D.
Right arrow Articles by Ramachandran, R.


Received for publication January 17, 2008.
Revised May 10, 2008.
Accepted for publication May 12, 2008.

Derivatized 2-furoyl-LIGRLO-amide, a versatile and selective probe for Proteinase-Activated Receptor 2 (PAR2): binding and visualization

Morley D. Hollenberg 1*, Bernard Renaux 1, Eric Hyun 1, Steeve Houle 1, Nathalie Vergnolle 2, Mahmoud Saifeddine 1, Rithwik Ramachandran 1

1 University of Calgary 2 University of Calgary and Universite Toulouse III Paul Sabatier

* Address correspondence to: E-mail: mhollenb{at}ucalgary.ca

Abstract

The Proteinase-Activated Receptor-2 (PAR2) activating peptide with an N-terminal furoyl group modification, 2-furoyl-LIGRLO-NH2 (2fLI), was derivatized via its free ornithine amino group to yield 3H-propionyl-2fLI and Alexa 594-2fLI that were used as receptor probes for ligand binding assays and receptor visualization both for cultured cells in vitro and for colonic epithelial cells in vivo. The binding of the radiolabeled and fluorescent PAR2 probes was shown to be present in PAR2-transfected KNRK cells but not in vector-alone-transfected cells and was abolished by pretreatment of cells with saturating concentrations of receptor-selective PAR2 peptide agonists like SLIGRL-NH2 and the parent agonist, 2fLI but not by reverse-sequence peptides like 2-furoyl-OLRGIL-NH2 that cannot activate PAR2. The relative orders of potencies for a series of PAR2 peptide agonists to compete for the binding of 3H-propionyl-2fLI (2fLI >> SLIGRL-NH2 {approx} trans-cinnamoyl-LIGRLO-NH2>SLIGKV-NH2>SLIGKT-NH2) mirrored qualitatively their relative potencies for PAR2-mediated calcium signaling in the same cells or for vasorelaxation in a rat aorta vascular assay. In the vascular assay, the potency of Alexa 594-2fLI was the same as 2fLI. We conclude that ornithine-derivatized 2fLI peptides are conveniently-synthesized PAR2 probes that will be of value for future studies of receptor binding and visualization studies.


Key words: PAR-2, Protease activated receptor, calcium, colon, fluorescent receptor labeling, ligand binding





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics.